Importance of BCR/ABL1 Transcript Type in CML

被引:0
作者
Cross, Nicholas C. P. [1 ,2 ]
机构
[1] Univ Southampton, Southampton, Hants, England
[2] Salisbury NHS Fdn Trust, Wessex Reg Genet Lab, Salisbury, Wilts, England
关键词
BCR/ABL1; CML; e14a2; e13a2; CHRONIC MYELOID-LEUKEMIA; E14A2; E13A2;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EXABS-113-
引用
收藏
页码:S20 / S22
页数:3
相关论文
共 15 条
[1]   Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets [J].
Adnan-Awad, Shady ;
Kim, Daehong ;
Hohtari, Helena ;
Javarappa, Komal Kumar ;
Brandstoetter, Tania ;
Mayer, Isabella ;
Potdar, Swapnil ;
Heckman, Caroline A. ;
Kytola, Soili ;
Porkka, Kimmo ;
Doma, Eszter ;
Sexl, Veronika ;
Kankainen, Matti ;
Mustjoki, Satu .
LEUKEMIA, 2021, 35 (07) :1964-1975
[2]   The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview [J].
Baccarani, Michele ;
Castagnetti, Fausto ;
Gugliotta, Gabriele ;
Rosti, Gianantonio ;
Soverini, Simona ;
Albeer, Ali ;
Pfirrmann, Markus ;
Bekadja, Mohamed-Amine ;
Entasoltan, Badra ;
Nachi, Mourad ;
Elghandour, Ashraf ;
El Sorady, Manal ;
Abdelfattah, Raafat ;
El Nahass, Yasser ;
Samra, Mohamed ;
Azzazi, Mohammed ;
Elsobki, Ezat ;
Moussa, Mohamed ;
Fahmy, Omar ;
Mattar, Mervat ;
Shehata, Samir Eid ;
Azmy, Emad ;
Bolarinwa, Rahman A. ;
Eid, Samir ;
Khelif, Abderrhaim ;
Hached, Farhat ;
Menif, Samia ;
Rahman, Hafizur ;
Huang, Xiaojun ;
Jiang, Qian ;
Ye, Yuanxin ;
Zhu, Huanling ;
Chen, Suning ;
Varma, Neelam ;
Ganesan, Prasanth ;
Gundeti, Sadashivudu ;
Malhotra, Hemant ;
Radhakrishnan, Vivek S. ;
Kumar, Lalit ;
Sharawat, Surender Kumar ;
Seth, Tulika ;
Ausekar, B. V. ;
Balasubramanian, Poonkuzhali ;
Poopak, Behzad ;
Inokuchi, Koiti ;
Kim, Dong-Wook ;
Al Kindi, Salam ;
Mirasol, Angelina ;
Qari, Mohammed ;
Goh, Yeow Tee .
LEUKEMIA, 2019, 33 (05) :1173-1183
[3]   The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib [J].
Castagnetti, Fausto ;
Gugliotta, Gabriele ;
Breccia, Massimo ;
Iurlo, Alessandra ;
Levato, Luciano ;
Albano, Francesco ;
Vigneri, Paolo ;
Abruzzese, Elisabetta ;
Rossi, Giuseppe ;
Rupoli, Serena ;
Cavazzini, Francesco ;
Martino, Bruno ;
Orlandi, Ester ;
Pregno, Patrizia ;
Annunziata, Mario ;
Usala, Emilio ;
Tiribelli, Mario ;
Sica, Simona ;
Bonifacio, Massimiliano ;
Fava, Carmen ;
Gherlinzoni, Filippo ;
Bocchia, Monica ;
Soverini, Simona ;
Bochicchio, Maria Teresa ;
Cavo, Michele ;
Giovanni, Martinelli ;
Saglio, Giuseppe ;
Pane, Fabrizio ;
Baccarani, Michele ;
Rosti, Gianantonio .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) :797-805
[4]  
CROSS NCP, 1994, LEUKEMIA, V8, P186
[5]   Chronic Myeloid Leukemia, Version 2.2021 [J].
Deininger, Michael W. ;
Shah, Neil P. ;
Altman, Jessica K. ;
Berman, Ellin ;
Bhatia, Ravi ;
Bhatnagar, Bhavana ;
DeAngelo, Daniel J. ;
Gotlib, Jason ;
Hobbs, Gabriela ;
Maness, Lori ;
Mead, Monica ;
Metheny, Leland ;
Mohan, Sanjay ;
Moore, Joseph O. ;
Naqvi, Kiran ;
Oehler, Vivian ;
Pallera, Arnel M. ;
Patnaik, Mrinal ;
Pratz, Keith ;
Pusic, Iskra ;
Rose, Michal G. ;
Smith, B. Douglas ;
Snyder, David S. ;
Sweet, Kendra L. ;
Talpaz, Moshe ;
Thompson, James ;
Yang, David T. ;
Gregory, Kristina M. ;
Sundar, Hema .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (10) :1385-1415
[6]   Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib [J].
Hanfstein, Benjamin ;
Lauseker, Michael ;
Hehlmann, Ruediger ;
Saussele, Susanne ;
Erben, Philipp ;
Dietz, Christian ;
Fabarius, Alice ;
Proetel, Ulrike ;
Schnittger, Susanne ;
Haferlach, Claudia ;
Krause, Stefan W. ;
Schubert, Joerg ;
Einsele, Hermann ;
Haenel, Mathias ;
Dengler, Jolanta ;
Falge, Christiane ;
Kanz, Lothar ;
Neubauer, Andreas ;
Kneba, Michael ;
Stegelmann, Frank ;
Pfreundschuh, Michael ;
Waller, Cornelius F. ;
Spiekermann, Karsten ;
Baerlocher, Gabriela M. ;
Pfirrmann, Markus ;
Hasford, Joerg ;
Hofmann, Wolf-Karsten ;
Hochhaus, Andreas ;
Mueller, Martin C. .
HAEMATOLOGICA, 2014, 99 (09) :1441-1447
[7]   European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia [J].
Hochhaus, A. ;
Baccarani, M. ;
Silver, R. T. ;
Schiffer, C. ;
Apperley, J. F. ;
Cervantes, F. ;
Clark, R. E. ;
Cortes, J. E. ;
Deininger, M. W. ;
Guilhot, F. ;
Hjorth-Hansen, H. ;
Hughes, T. P. ;
Janssen, J. J. W. M. ;
Kantarjian, H. M. ;
Kim, D. W. ;
Larson, R. A. ;
Lipton, J. H. ;
Mahon, F. X. ;
Mayer, J. ;
Nicolini, F. ;
Niederwieser, D. ;
Pane, F. ;
Radich, J. P. ;
Rea, D. ;
Richter, J. ;
Rosti, G. ;
Rousselot, P. ;
Saglio, G. ;
Saussele, S. ;
Soverini, S. ;
Steegmann, J. L. ;
Turkina, A. ;
Zaritskey, A. ;
Hehlmann, R. .
LEUKEMIA, 2020, 34 (04) :966-984
[8]   Two patients with novel BCR ABL fusion transcripts (e8/a2 and e13/a2) resulting from translocation breakpoints within BCR exons [J].
How, GF ;
Lim, LC ;
Kulkarni, S ;
Tan, LT ;
Tan, P ;
Cross, NCP .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (02) :434-436
[9]   Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors [J].
Jain, Preetesh ;
Kantarjian, Hagop ;
Patel, Keyur P. ;
Gonzalez, Graciela Nogueras ;
Luthra, Rajyalakshmi ;
Shamanna, Rashmi Kanagal ;
Sasaki, Koji ;
Jabbour, Elias ;
Romo, Carlos Guillermo ;
Kadia, Tapan M. ;
Pemmaraju, Naveen ;
Daver, Naval ;
Borthakur, Gautam ;
Estrov, Zeev ;
Ravandi, Farhad ;
O'Brien, Susan ;
Cortes, Jorge .
BLOOD, 2016, 127 (10) :1269-1275
[10]   Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript [J].
Lucas, Claire M. ;
Harris, Robert J. ;
Giannoudis, Athina ;
Davies, Andrea ;
Knight, Katy ;
Watmough, Sarah J. ;
Wang, Lihui ;
Clark, Richard E. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (10) :1362-1367